Lyell Wealth Management LP Has $2.79 Million Position in iShares Biotechnology ETF (NASDAQ:IBB)

Lyell Wealth Management LP reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 6.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 20,565 shares of the financial services provider’s stock after selling 1,377 shares during the period. Lyell Wealth Management LP’s holdings in iShares Biotechnology ETF were worth $2,794,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in IBB. Glass Jacobson Investment Advisors llc grew its holdings in shares of iShares Biotechnology ETF by 150.6% during the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 122 shares in the last quarter. Values First Advisors Inc. purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at $43,000. Tennessee Valley Asset Management Partners purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at $44,000. Horizon Bancorp Inc. IN purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at $44,000. Finally, Massmutual Trust Co. FSB ADV grew its holdings in shares of iShares Biotechnology ETF by 164.2% during the 4th quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock valued at $49,000 after acquiring an additional 225 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.2 %

NASDAQ:IBB traded down $0.26 during trading hours on Wednesday, reaching $127.76. The company’s stock had a trading volume of 1,238,619 shares, compared to its average volume of 1,805,245. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $141.16. The business’s 50-day moving average is $134.81 and its 200-day moving average is $129.75.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were issued a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.